MAGRX
Price
$33.63
Change
-$0.12 (-0.36%)
Updated
Oct 7 closing price
Net Assets
155.03M
PRNEX
Price
$43.02
Change
-$0.01 (-0.02%)
Updated
Oct 7 closing price
Net Assets
2.48B
Interact to see
Advertisement

MAGRX vs PRNEX

Header iconMAGRX vs PRNEX Comparison
Open Charts MAGRX vs PRNEXBanner chart's image
BlackRock Natural Resources Instl
Price$33.63
Change-$0.12 (-0.36%)
VolumeN/A
Net Assets155.03M
T. Rowe Price New Era
Price$43.02
Change-$0.01 (-0.02%)
VolumeN/A
Net Assets2.48B
MAGRX vs PRNEX Comparison Chart in %
View a ticker or compare two or three
VS
MAGRX vs. PRNEX commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MAGRX is a Hold and PRNEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PRNEX has more cash in the bank: 2.48B vs. MAGRX (155M). MAGRX pays higher dividends than PRNEX: MAGRX (2.44) vs PRNEX (1.81). MAGRX was incepted earlier than PRNEX: MAGRX (37 years) vs PRNEX (57 years). MAGRX (0.90) is less costly to investors than PRNEX (0.77). MAGRX is a more actively managed with annual turnover of: 79.00 vs. PRNEX (24.30). PRNEX has a lower initial minimum investment than MAGRX: PRNEX (2500) vs MAGRX (2000000). PRNEX annual gain was more profitable for investors over the last year : 4.04 vs. MAGRX (2.37). MAGRX return over 5 years is better than : 81.22 vs. PRNEX (65.83).
MAGRXPRNEXMAGRX / PRNEX
Total Expense Ratio0.900.77117%
Annual Report Gross Expense Ratio0.900.77117%
Fund Existence37 years57 years-
Gain YTD17.13315.797108%
Front LoadN/AN/A-
Min. Initial Investment2000000250080,000%
Min. Initial Investment IRAN/AN/A-
Net Assets155M2.48B6%
Annual Yield % from dividends2.441.81135%
Returns for 1 year2.374.0459%
Returns for 3 years20.5519.63105%
Returns for 5 years81.2265.83123%
Returns for 10 years-11.0463.87-17%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SDMGX22.60N/A
N/A
Sit Developing Markets Growth
SHSSX67.81N/A
N/A
BlackRock Health Sciences Opps Instl
RLCAX9.33N/A
N/A
Columbia Disciplined Value A
QQMNX20.93N/A
N/A
Federated Hermes MDT Market Neutral IS
FCUEX20.59-0.15
-0.72%
NYLI PineStone U.S. Equity Class A